According to research that was partially funded by MGC Pharmaceuticals Ltd. in Australia and published in the journal Cells, the cannabis extract may have the ability to interact with receptors on particular types of melanoma cells, which might make it useful as an adjuvant treatment for malignant melanoma. To fully evaluate its safety and effectiveness, however, more preclinical research is necessary.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…